You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Life & Medical Care

Global Tumor-Specific Antigen Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application

Tumor-specific Antigen is a new Antigen that is expressed on the surface of certain Tumor cells but not on normal cells.Such antigens may be present in tumors of the same tissue type in different individuals.Tumor-specific antigens help the body develop an immune response to cancer cells.They could be used as potential targets for targeted therapy or immunotherapy to help improve the body's immune system to kill more cancer cells.Tumor-specific antigens can also be used in laboratory tests to help identify certain types of cancer.
Market Analysis and Insights: Global Tumor-Specific Antigen Market
The global Tumor-Specific Antigen market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Tumor-Specific Antigen Scope and Segment
The global Tumor-Specific Antigen market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Tumor-Specific Antigen market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.
The major regions covered in the report are North America, Europe, China, Rest of Asia Pacific, Central & South America, Middle East & Africa, etc. It includes revenue analysis of each region for the year 2015 to 2026.
By the type, the market is primarily split into
Coding Region
Non-Coding Region
By the application, this report covers the following segments
Drug Discovery and Development
Diagnostics
Clinical and Basic Research
Others
Competitive Landscape:
The Tumor-Specific Antigen key manufacturers in this market include:
Agilent Technologies
Creative Diagnostics
Go Therapeutics
Lee Biosolutions
Bio-Rad
Biomrieux
Caris Life Sciences
Roche
Abcam
Merck Group
PerkinElmer
OriGene Technologies
1 Market Overview of Tumor-Specific Antigen
1.1 Tumor-Specific Antigen Market Overview
1.1.1 Tumor-Specific Antigen Product Scope
1.1.2 Market Status and Outlook
1.2 Global Tumor-Specific Antigen Market Size Overview by Region 2015 VS 2020 VS 2026
1.3 Global Tumor-Specific Antigen Market Size by Region (2015-2026)
1.4 Global Tumor-Specific Antigen Historic Market Size by Region (2015-2020)
1.5 Global Tumor-Specific Antigen Market Size Forecast by Region (2021-2026)
1.6 Key Regions, Tumor-Specific Antigen Market Size YoY Growth (2015-2026)
1.6.1 North America Tumor-Specific Antigen Market Size YoY Growth (2015-2026)
1.6.2 Europe Tumor-Specific Antigen Market Size YoY Growth (2015-2026)
1.6.3 China Tumor-Specific Antigen Market Size YoY Growth (2015-2026)
1.6.4 Rest of Asia Pacific Tumor-Specific Antigen Market Size YoY Growth (2015-2026)
1.6.5 Latin America Tumor-Specific Antigen Market Size YoY Growth (2015-2026)
1.6.6 Middle East & Africa Tumor-Specific Antigen Market Size YoY Growth (2015-2026)

2 Tumor-Specific Antigen Market Overview by Type
2.1 Global Tumor-Specific Antigen Market Size by Type: 2015 VS 2020 VS 2026
2.2 Global Tumor-Specific Antigen Historic Market Size by Type (2015-2020)
2.3 Global Tumor-Specific Antigen Forecasted Market Size by Type (2021-2026)
2.4 Coding Region
2.5 Non-Coding Region

3 Tumor-Specific Antigen Market Overview by Application
3.1 Global Tumor-Specific Antigen Market Size by Application: 2015 VS 2020 VS 2026
3.2 Global Tumor-Specific Antigen Historic Market Size by Application (2015-2020)
3.3 Global Tumor-Specific Antigen Forecasted Market Size by Application (2021-2026)
3.4 Drug Discovery and Development
3.5 Diagnostics
3.6 Clinical and Basic Research
3.7 Others

4 Global Tumor-Specific Antigen Competition Analysis by Players
4.1 Global Tumor-Specific Antigen Market Size (Million US$) by Players (2015-2020)
4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tumor-Specific Antigen as of 2019)
4.3 Date of Key Manufacturers Enter into Tumor-Specific Antigen Market
4.4 Global Top Players Tumor-Specific Antigen Headquarters and Area Served
4.5 Key Players Tumor-Specific Antigen Product Solution and Service
4.6 Competitive Status
4.6.1 Tumor-Specific Antigen Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans

5 Company (Top Players) Profiles and Key Data
5.1 Agilent Technologies
5.1.1 Agilent Technologies Profile
5.1.2 Agilent Technologies Main Business and Company’s Total Revenue
5.1.3 Agilent Technologies Products, Services and Solutions
5.1.4 Agilent Technologies Revenue (US$ Million) (2015-2020)
5.1.5 Agilent Technologies Recent Development and Reaction to Covid-19
5.2 Creative Diagnostics
5.2.1 Creative Diagnostics Profile
5.2.2 Creative Diagnostics Main Business and Company’s Total Revenue
5.2.3 Creative Diagnostics Products, Services and Solutions
5.2.4 Creative Diagnostics Revenue (US$ Million) (2015-2020)
5.2.5 Creative Diagnostics Recent Development and Reaction to Covid-19
5.3 Go Therapeutics
5.5.1 Go Therapeutics Profile
5.3.2 Go Therapeutics Main Business and Company’s Total Revenue
5.3.3 Go Therapeutics Products, Services and Solutions
5.3.4 Go Therapeutics Revenue (US$ Million) (2015-2020)
5.3.5 Lee Biosolutions Recent Development and Reaction to Covid-19
5.4 Lee Biosolutions
5.4.1 Lee Biosolutions Profile
5.4.2 Lee Biosolutions Main Business and Company’s Total Revenue
5.4.3 Lee Biosolutions Products, Services and Solutions
5.4.4 Lee Biosolutions Revenue (US$ Million) (2015-2020)
5.4.5 Lee Biosolutions Recent Development and Reaction to Covid-19
5.5 Bio-Rad
5.5.1 Bio-Rad Profile
5.5.2 Bio-Rad Main Business and Company’s Total Revenue
5.5.3 Bio-Rad Products, Services and Solutions
5.5.4 Bio-Rad Revenue (US$ Million) (2015-2020)
5.5.5 Bio-Rad Recent Development and Reaction to Covid-19
5.6 Biomrieux
5.6.1 Biomrieux Profile
5.6.2 Biomrieux Main Business and Company’s Total Revenue
5.6.3 Biomrieux Products, Services and Solutions
5.6.4 Biomrieux Revenue (US$ Million) (2015-2020)
5.6.5 Biomrieux Recent Development and Reaction to Covid-19
5.7 Caris Life Sciences
5.7.1 Caris Life Sciences Profile
5.7.2 Caris Life Sciences Main Business and Company’s Total Revenue
5.7.3 Caris Life Sciences Products, Services and Solutions
5.7.4 Caris Life Sciences Revenue (US$ Million) (2015-2020)
5.7.5 Caris Life Sciences Recent Development and Reaction to Covid-19
5.8 Roche
5.8.1 Roche Profile
5.8.2 Roche Main Business and Company’s Total Revenue
5.8.3 Roche Products, Services and Solutions
5.8.4 Roche Revenue (US$ Million) (2015-2020)
5.8.5 Roche Recent Development and Reaction to Covid-19
5.9 Abcam
5.9.1 Abcam Profile
5.9.2 Abcam Main Business and Company’s Total Revenue
5.9.3 Abcam Products, Services and Solutions
5.9.4 Abcam Revenue (US$ Million) (2015-2020)
5.9.5 Abcam Recent Development and Reaction to Covid-19
5.10 Merck Group
5.10.1 Merck Group Profile
5.10.2 Merck Group Main Business and Company’s Total Revenue
5.10.3 Merck Group Products, Services and Solutions
5.10.4 Merck Group Revenue (US$ Million) (2015-2020)
5.10.5 Merck Group Recent Development and Reaction to Covid-19
5.11 PerkinElmer
5.11.1 PerkinElmer Profile
5.11.2 PerkinElmer Main Business and Company’s Total Revenue
5.11.3 PerkinElmer Products, Services and Solutions
5.11.4 PerkinElmer Revenue (US$ Million) (2015-2020)
5.11.5 PerkinElmer Recent Development and Reaction to Covid-19
5.12 OriGene Technologies
5.12.1 OriGene Technologies Profile
5.12.2 OriGene Technologies Main Business and Company’s Total Revenue
5.12.3 OriGene Technologies Products, Services and Solutions
5.12.4 OriGene Technologies Revenue (US$ Million) (2015-2020)
5.12.5 OriGene Technologies Recent Development and Reaction to Covid-19

6 North America Tumor-Specific Antigen by Players and by Application
6.1 North America Tumor-Specific Antigen Market Size and Market Share by Players (2015-2020)
6.2 North America Tumor-Specific Antigen Market Size by Application (2015-2020)

7 Europe Tumor-Specific Antigen by Players and by Application
7.1 Europe Tumor-Specific Antigen Market Size and Market Share by Players (2015-2020)
7.2 Europe Tumor-Specific Antigen Market Size by Application (2015-2020)

8 China Tumor-Specific Antigen by Players and by Application
8.1 China Tumor-Specific Antigen Market Size and Market Share by Players (2015-2020)
8.2 China Tumor-Specific Antigen Market Size by Application (2015-2020)

9 Rest of Asia Pacific Tumor-Specific Antigen by Players and by Application
9.1 Rest of Asia Pacific Tumor-Specific Antigen Market Size and Market Share by Players (2015-2020)
9.2 Rest of Asia Pacific Tumor-Specific Antigen Market Size by Application (2015-2020)

10 Latin America Tumor-Specific Antigen by Players and by Application
10.1 Latin America Tumor-Specific Antigen Market Size and Market Share by Players (2015-2020)
10.2 Latin America Tumor-Specific Antigen Market Size by Application (2015-2020)

11 Middle East & Africa Tumor-Specific Antigen by Players and by Application
11.1 Middle East & Africa Tumor-Specific Antigen Market Size and Market Share by Players (2015-2020)
11.2 Middle East & Africa Tumor-Specific Antigen Market Size by Application (2015-2020)

12 Tumor-Specific Antigen Market Dynamics
12.1 Covid-19 Impact: Industry Trends
12.2 Covid-19 Impact: Market Drivers
12.3 Covid-19 Impact: Market Challenges
12.4 Porter’s Five Forces Analysis

13 Research Finding /Conclusion

14 Methodology and Data Source
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
14.4 Author List
  • FORMAT: PDF
  • PUBLISHED DATE: Nov, 2020
  • NO OF PAGES: 125